Slide 1: opett Y
opett Y
Slide 2: Disclaimer
DISCLAIMER This presentation also contains estimates and other statistical data made by independent parties and by the Company relating to market size the concentration of our voting power as a result of our dual class structure; our status as a foreign private issuer; and other risk factors set and
Slide 3: Our vision is to transform the global beauty & wellness market
OUR VISION IS TO TRANSFORM THE GLOBAL BEAUTY & WELLNESS MARKET THROUGH ISRAELI TECHNOLOGY & ENTREPRENEURIAL THINKING FOR THE BENEFIT OF CONSUMERS ALL OVER THE WORLD. 3
Slide 4: Our technology platform supports a portfolio of powerhouse brands
OUR TECHNOLOGY PLATFORM SUPPORTS A PORTFOLIO OF POWERHOUSE BRANDS 4
Slide 5: $ODD Financial Highlights
$ODD FINANCIAL HIGHLIGHTS $555M $127M $252M Net revenue, Adjusted EBITDA1, Cash, cash equivalents, LTM Q124 LTM Q124 & investments4 +39% 23% $111M YoY net revenue Adjusted EBITDA2 Free cash flow3, growth, LTM Q124 margin, LTM Q124 LTM Q124 Note: 1. Adjusted EBITDA is a supplemental measure of our pe
Slide 6: A rare combination of scale + growth + profitability
A RARE COMBINATION OF SCALE + GROWTH + PROFITABILITY +57% +46% NET REVENUE GROWTH1 +101% $509M +28% +83% $325M $223M $212M NET REVENUE $166M $107M ADJUSTED EBITDA2 $27M $39M $28M $48M FY21 FY22 FY23 Q123 Q124 Note: 1. Percentages reflect year-over-year growth rates for the same period of the prior y
Slide 7: Q1 2024 results exceeded guidance
Q1 2024 RESULTS EXCEEDED GUIDANCE Q1 2024 ACTUAL GUIDANCE NET REVENUE GROWTH 28% 23 to 25% GROSS MARGIN 73.8% 71.0% ADJUSTED EBITDA1 $48mn $43mn to $45mn ADJUSTED DILUTED EPS2 $0.61 $0.47 to 0.50 Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by, or presen
Slide 8: Raised FY 2024 and introduced Q2 2024 financial outlook
RAISED FY 2024 AND INTRODUCED Q2 2024 FINANCIAL OUTLOOK GUIDANCE PRIOR Q2 2024 FY 2024 FY 2024 Current Current Issued March 2024 NET REVENUE $185 to 189mn $626 to 635mn $620 to 630mn GROSS MARGIN 71.0% 71.0% 70.5% ADJUSTED EBITDA1 $53 to 56mn $139 to 143mn $136 to 140mn ADJUSTED DILUTED EPS2 $0.61 t
Slide 9: Q1 2024 Highlights
Q1 2024 HIGHLIGHTS In millions Q1 2024 vs Q1 2023 Net Revenue $211.6 +28% Gross Margin 73.8% +284 bps 1 Adjusted EBITDA $48.1 +69% 2 Adjusted EBITDA margin 22.7% +559 bps 3 Adjusted Diluted EPS $0.61 +64% Note: 1. Adjusted EBITDA is a supplemental measure of our performance that is not required by,
Slide 10: FY 2023 Highlights
FY 2023 HIGHLIGHTS In millions FY 2023 vs FY 2022 Net Revenue $508.7 +57% Gross Margin 70.4% +320 bps 1 Adjusted EBITDA $107.3 +172% 2 Adjusted EBITDA margin 21.1% +900 bps 3 Adjusted Diluted EPS $1.31 nm 4 Free-cash flow $85.4 +133% Note: 1. Adjusted EBITDA is a supplemental measure of our performa
Slide 11: Appendix
APPENDIX 11
Slide 12: Reconciliations to adjusted metrics
RECONCILIATIONS TO ADJUSTED METRICS U.S. dollar in thousands (except per share data) Three Months Ended Twelve Months Ended March 31, December 31, 2024 2023 2023 2022 (Unaudited) (Unaudited) Net Income $ 32,983 $ 19,590 $ 58,534 $ 21,728 Financial expenses (income), net (2,955) 157 (4,283) (1,247) T
Slide 13: Reconciliations to adjusted metrics
RECONCILIATIONS TO ADJUSTED METRICS U.S. dollar in thousands (except per share data) Three Months Ended March 31, Year Ended December 31, 2024 2023 2023 2022 Adjusted net Income $ 38,380 $ 21,034 $ 76,713 $ 27,298 Class A Ordinary Shares 51,120,023 39,938,692 44,617,750 37,254,842 Class B Ordinary S
Slide 14: Reconciliation of net cash provided by operating activities to free cash flow
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW U.S. dollar in thousands (except per share data) Year Ended December 31, 2023 2022 (Unaudited) Net operating cash flow $ 87,455 $ 39,032 Purchase of property and equipment (2,101) (2,347) Free cash flow1 $ 85,354 $ 36,685